{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"columns":[{"gene":"","key":"MONDO:0014546/OMIM:616231","label":"Myopathy, vacuolar, with CASQ1 aggregates","mondoId":"MONDO:0014546","onsetQualifier":null,"recordKeys":["324e3af7333d80af0749835f61fdc760baccf0c6741cb2268007e12414c1f49e","4388a58e83b64965ad39db7ef2c915da5242d3c5f778fd422190927fa8ff88db","6e8b4cf6e7dd4d55c00894be91656384083b5148df0c77cf79d804176786ded2","8c9bfa9d02423b7db9c1b955b0c7804153748be244a5dd97737b8ec23e2d3fda","c4e3e150402ddd236ad42d12368dcee0af17e5b32fda2eb0316a770344351301","d12dba3d811e5f9eb2a19258f160a0ad6aceaafa7bdf9827c73f0bfc42dd5f0c","d6c87ef7c6f909b43014dfee065aca432b11b4e2cff8962e1517ad65deb34b3b"],"recordQualifiers":{},"scopeLabel":"OMIM:616231","sourceIds":["OMIM:616231"],"sourceScope":"This column retains the native source entry. It is not a pooled estimate for the umbrella condition."},{"gene":"","key":"MONDO:0014546/ORPHA:88635","label":"Vacuolar myopathy with sarcoplasmic reticulum protein aggregates","mondoId":"MONDO:0014546","onsetQualifier":null,"recordKeys":["77e495efc49cd92d37a79259b218e7762bbc342edc19b4fa8106bdd961bcb5cb","c643237a877d735ef3055d765a387d973404fe87507835c488f79d0459c01b23"],"recordQualifiers":{},"scopeLabel":"ORPHA:88635","sourceIds":["ORPHA:88635"],"sourceScope":"This column retains the native source entry. It is not a pooled estimate for the umbrella condition."}],"comparison":{"collapseColumnsLabel":"Show initial comparisons","defaultColumnKeys":["MONDO:0014546/OMIM:616231","MONDO:0014546/ORPHA:88635"],"expandColumnsLabel":"Compare all source entries","intro":"Compare the original source entries. Different entries may describe different patient groups.","primaryFeatureIds":[],"scopeNoteHtml":"<p>Each column keeps its native condition scope. Initial features are displayed alphabetically, not ranked by clinical importance. Counts remain separate, and an empty cell does not mean a feature cannot occur.</p>"},"coverage":{"countRecords":5,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":9,"sourceGroups":{"omim":2,"orphanet":2,"published":5}},"features":[{"hpoId":"HP:0003388","label":"Easy fatigability","primary":false},{"hpoId":"HP:0003236","label":"Elevated circulating creatine kinase activity","primary":false},{"hpoId":"HP:0034940","label":"Muscle fiber calsequestrin 1-containing inclusion bodies","primary":false},{"hpoId":"HP:0003394","label":"Muscle spasm","primary":false},{"hpoId":"HP:0001324","label":"Muscle weakness","primary":false},{"hpoId":"HP:0003326","label":"Myalgia","primary":false},{"hpoId":"HP:0003198","label":"Myopathy","primary":false},{"hpoId":"HP:0003701","label":"Proximal muscle weakness","primary":false}],"ledeHtml":"A patient-friendly description is not yet available in the ingested narrative sources for this condition.","mondoId":"MONDO:0014546","records":[{"frequencyKind":"count","key":"324e3af7333d80af0749835f61fdc760baccf0c6741cb2268007e12414c1f49e","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:616231","disease_name":"Myopathy, vacuolar, with CASQ1 aggregates","evidence":"PCS","frequency_raw":"1/10","hpo_id":"HP:0001324","is_excluded":false,"label":"Muscle weakness","onset_id":null,"reference":"PMID:26136523","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"4388a58e83b64965ad39db7ef2c915da5242d3c5f778fd422190927fa8ff88db","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:616231","disease_name":"Myopathy, vacuolar, with CASQ1 aggregates","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0003388","is_excluded":false,"label":"Easy fatigability","onset_id":null,"reference":"OMIM:616231","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"count","key":"6e8b4cf6e7dd4d55c00894be91656384083b5148df0c77cf79d804176786ded2","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:616231","disease_name":"Myopathy, vacuolar, with CASQ1 aggregates","evidence":"PCS","frequency_raw":"2/2","hpo_id":"HP:0034940","is_excluded":false,"label":"Muscle fiber calsequestrin 1-containing inclusion bodies","onset_id":null,"reference":"PMID:30258016","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"77e495efc49cd92d37a79259b218e7762bbc342edc19b4fa8106bdd961bcb5cb","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:88635","disease_name":"Vacuolar myopathy with sarcoplasmic reticulum protein aggregates","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0003236","is_excluded":false,"label":"Elevated circulating creatine kinase activity","onset_id":null,"reference":"ORPHA:88635","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"8c9bfa9d02423b7db9c1b955b0c7804153748be244a5dd97737b8ec23e2d3fda","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:616231","disease_name":"Myopathy, vacuolar, with CASQ1 aggregates","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0003701","is_excluded":false,"label":"Proximal muscle weakness","onset_id":null,"reference":"OMIM:616231","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"count","key":"c4e3e150402ddd236ad42d12368dcee0af17e5b32fda2eb0316a770344351301","raw":{"aspect":"P","body_system":"other","disease_id":"OMIM:616231","disease_name":"Myopathy, vacuolar, with CASQ1 aggregates","evidence":"PCS","frequency_raw":"3/10","hpo_id":"HP:0003326","is_excluded":false,"label":"Myalgia","onset_id":null,"reference":"PMID:26136523","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"c643237a877d735ef3055d765a387d973404fe87507835c488f79d0459c01b23","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:88635","disease_name":"Vacuolar myopathy with sarcoplasmic reticulum protein aggregates","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0003198","is_excluded":false,"label":"Myopathy","onset_id":null,"reference":"ORPHA:88635","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"d12dba3d811e5f9eb2a19258f160a0ad6aceaafa7bdf9827c73f0bfc42dd5f0c","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:616231","disease_name":"Myopathy, vacuolar, with CASQ1 aggregates","evidence":"PCS","frequency_raw":"4/10","hpo_id":"HP:0003394","is_excluded":false,"label":"Muscle spasm","onset_id":null,"reference":"PMID:26136523","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"d6c87ef7c6f909b43014dfee065aca432b11b4e2cff8962e1517ad65deb34b3b","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:616231","disease_name":"Myopathy, vacuolar, with CASQ1 aggregates","evidence":"PCS","frequency_raw":"8/10","hpo_id":"HP:0003236","is_excluded":false,"label":"Elevated circulating creatine kinase activity","onset_id":null,"reference":"PMID:26136523","source_release":"2026-06-23"},"sourceGroups":["published"]}],"referenceLabels":{},"references":{"causeHtml":"<p>No mapped MedlinePlus condition document in this snapshot.</p>","identityNote":"MONDO defines condition identity and route membership. Native evidence populations and narrative coverage retain their separate scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>No MedlinePlus narrative has been mapped to this MONDO condition. Feature annotations, when available, are retained below.</p>","key":"overview","title":"Condition overview"}],"sharedSources":[],"slug":"myopathy-due-to-calsequestrin-and-serca1-protein-overload","sourceDocuments":[],"sourceNote":"MONDO condition identity; scoped MedlinePlus enrichment where available; original HPO annotations.","takeawayHtml":"Cause information is not available in the mapped narrative sources for this condition.","title":"myopathy due to calsequestrin and SERCA1 protein overload"},"schemaVersion":1}